{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:10:17Z","timestamp":1768446617939,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11307-025-02059-4","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:31:08Z","timestamp":1763141468000},"page":"966-975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of Early Dynamic 18F-FDG PET\/CT Imaging for Predicting EGFR and TP53 Mutations in Lung Adenocarcinoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beilei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"2059_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2059_CR2","unstructured":"Jackson RS, Schlarman TC, Hubble WL, Osman MM (2006)\u00a0Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol (1):29\u201333"},{"key":"2059_CR3","doi-asserted-by":"publisher","first-page":"20200810","DOI":"10.1259\/bjr.20200810","volume":"95","author":"X Zhang","year":"2022","unstructured":"Zhang X et al (2022) Effect of metformin on 18F-fluorodeoxyglucose uptake and positron emission tomographic imaging. Br J Radiol 95:20200810","journal-title":"Br J Radiol"},{"key":"2059_CR4","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00259-021-05623-6","volume":"49","author":"H Sari","year":"2022","unstructured":"Sari H et al (2022) First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging 49:1997\u20132009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2059_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2967\/jnumed.116.188029","volume":"58","author":"AA Lammertsma","year":"2017","unstructured":"Lammertsma AA (2017) Forward to the past: the case for quantitative PET imaging. J Nucl Med 58:1019\u20131024","journal-title":"J Nucl Med"},{"key":"2059_CR6","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00259-006-0319-8","volume":"34","author":"LG Strauss","year":"2007","unstructured":"Strauss LG et al (2007) Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection? Eur J Nucl Med Mol Imaging 34:868\u2013877","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2059_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2967\/jnumed.121.263518","volume":"63","author":"AR Pantel","year":"2022","unstructured":"Pantel AR, Viswanath V, Muzi M, Doot RK, Mankoff DA (2022) Principles of tracer kinetic analysis in oncology, part I: principles and overview of methodology. J Nucl Med 63(3):342\u2013352","journal-title":"J Nucl Med"},{"key":"2059_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00259-023-06526-4","volume":"51","author":"G Liu","year":"2024","unstructured":"Liu G (2024) Dynamic total-body PET\/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics. Eur J Nucl Med Mol Imaging 51:1371\u20131382","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2059_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-023-01442-5","volume":"14","author":"T Wang","year":"2023","unstructured":"Wang T et al (2023) Short-term PET-derived kinetic estimation for the diagnosis of hepatocellular carcinoma: a combination of the maximum-slope method and dual-input three-compartment model. Insights Imaging 14:98","journal-title":"Insights Imaging"},{"key":"2059_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-022-00492-w","volume":"9","author":"Z Wang","year":"2022","unstructured":"Wang Z et al (2022) Comparison between a dual-time-window protocol and other simplified protocols for dynamic total-body 18F-FDG PET imaging. EJNMMI Phys 9:63","journal-title":"EJNMMI Phys"},{"key":"2059_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.822708","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H (2022) Improved clinical workflow for whole-body Patlak parametric imaging using two short dynamic acquisitions. Front Oncol 12:822708","journal-title":"Front Oncol"},{"key":"2059_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.725387","volume":"8","author":"L Indovina","year":"2021","unstructured":"Indovina L et al (2021) Short 2-[18F]fluoro-2-deoxy-D-glucose PET dynamic acquisition protocol to evaluate the influx rate constant by regional Patlak graphical analysis in patients with non-small-cell lung cancer. Front Med 8:725387","journal-title":"Front Med"},{"key":"2059_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2967\/jnumed.120.261651","volume":"63","author":"Y Wu","year":"2022","unstructured":"Wu Y et al (2022) Whole-body parametric imaging of18 f-FDG PET using uEXPLORER with reduced scanning time. J Nucl Med 63:622\u2013628","journal-title":"J Nucl Med"},{"key":"2059_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejmp.2020.11.004","volume":"80","author":"R Samimi","year":"2020","unstructured":"Samimi R, Kamali-Asl A, Geramifar P, Van Den Hoff J, Rahmim A (2020) Short-duration dynamic FDG PET imaging: optimization and clinical application. Phys Med 80:193\u2013200","journal-title":"Phys Med"},{"key":"2059_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35278","author":"AM Filho","year":"2025","unstructured":"Filho AM (2025) The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Intl Journal of Cancer. https:\/\/doi.org\/10.1002\/ijc.35278","journal-title":"Intl Journal of Cancer"},{"key":"2059_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS (2021) Lung cancer. Lancet 398:535\u2013554","journal-title":"Lancet"},{"key":"2059_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jtho.2021.01.1615","volume":"16","author":"Y Yang","year":"2021","unstructured":"Yang Y et al (2021) Decoding the evolutionary response to Ensartinib in patients with ALK-positive NSCLC by dynamic circulating tumor DNA sequencing. J Thorac Oncol 16:827\u2013839","journal-title":"J Thorac Oncol"},{"key":"2059_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.critrevonc.2015.11.019","volume":"99","author":"C Deben","year":"2016","unstructured":"Deben C, Deschoolmeester V, Lardon F, Rolfo C, Pauwels P (2016) TP53 and MDM2 genetic alterations in non-small cell lung cancer: evaluating their prognostic and predictive value. Crit Rev Oncol Hematol 99:63\u201373","journal-title":"Crit Rev Oncol Hematol"},{"key":"2059_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246127","volume":"14","author":"X Le","year":"2022","unstructured":"Le X et al (2022) TP53 co-mutation status association with clinical outcomes in patients with EGFR-mutant non-small cell lung cancer. Cancers (Basel) 14:6127","journal-title":"Cancers (Basel)"},{"key":"2059_CR20","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13504","volume":"24","author":"B Lan","year":"2022","unstructured":"Lan B, Zhao N, Du K, Leng B (2022) Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: an updated systematic review and meta-analysis. Oncol Lett 24:384","journal-title":"Oncol Lett"},{"key":"2059_CR21","doi-asserted-by":"publisher","unstructured":"Liu G, Xu H, Hu P, Tan H, Zhang Y, Yu H, Li X, Shi H (2021) Kinetic metrics of 18F-FDG in normal human organs identified by systematic dynamic total-body positron emission tomography. Eur J Nucl Med Mol Imaging 48(8):2363\u20132372. https:\/\/doi.org\/10.1007\/s00259-020-05124-y","DOI":"10.1007\/s00259-020-05124-y"},{"key":"2059_CR22","doi-asserted-by":"publisher","unstructured":"Liu G, Hu P, Yu H, Tan H, Zhang Y, Yin H, Yiqiu T, Hongyan Z, Yan Y, Gu HJ, Shi H (2021) Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of 18F-FDG in healthy volunteers. Eur J Nucl Med Mol Imaging 48(8):2373\u20132383. https:\/\/doi.org\/10.1007\/s00259-020-05173-3","DOI":"10.1007\/s00259-020-05173-3"},{"key":"2059_CR23","doi-asserted-by":"publisher","unstructured":"Fan Y, Liu Y, Ouyang X, Su J, Zhou X, Jia Q, Chen W, Chen W, Liu X (2025) Prediction of EGFR mutation status and its subtypes in non-small cell lung cancer based on 18F-FDG PET\/CT radiological features. Nucl Med Commun 46(4):326\u2013336. https:\/\/doi.org\/10.1097\/MNM.0000000000001948","DOI":"10.1097\/MNM.0000000000001948"},{"key":"2059_CR24","doi-asserted-by":"publisher","unstructured":"Zhang J, Zhao X, Zhao Y, Zhang J, Zhang Z, Wang J, Wang J, Dai M, Han J (2020) Value of pre-therapy 18F-FDG PET\/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 47(5):1137\u20131146. https:\/\/doi.org\/10.1007\/s00259-019-04592-1","DOI":"10.1007\/s00259-019-04592-1"},{"key":"2059_CR25","doi-asserted-by":"publisher","unstructured":"Yip SS, Kim J, Coroller TP, Parmar C, Velazquez ER, Huynh E, Mak RH, Aerts\u00a0HJWL (2017) Associations between somatic mutations and metabolic imaging phenotypes in non\u2013small cell lung cancer. J Nucl Med 58(4):569\u2013576. https:\/\/doi.org\/10.2967\/jnumed.116.181826","DOI":"10.2967\/jnumed.116.181826"},{"key":"2059_CR26","doi-asserted-by":"publisher","unstructured":"Huang L, Kong W, Luo Y, Xie H, Liu J, Zhang X, Zhang G (2024) Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET\/CT images using deep learning. Front Oncol 14. https:\/\/doi.org\/10.3389\/fonc.2024.1458374","DOI":"10.3389\/fonc.2024.1458374"},{"key":"2059_CR27","doi-asserted-by":"publisher","unstructured":"Zuo Y, Liu Q, Li N, Li P, Fang Y, Bian L, Zhang J, Song S (2024) Explainable 18F-FDG PET\/CT radiomics model for predicting EGFR mutation status in lung adenocarcinoma: a two-center study. J Can Res Clin Oncol 150(10). https:\/\/doi.org\/10.1007\/s00432-024-05998-7","DOI":"10.1007\/s00432-024-05998-7"},{"key":"2059_CR28","doi-asserted-by":"publisher","unstructured":"Li S, Hu Y, Tian C, Luan J, Zhang X, Wei Q, Li X, Bian Y (2025) Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LUAD) by 18F-FDG PET\/CT radiomics. Clin Transl Oncol 27(4):1506\u20131515. https:\/\/doi.org\/10.1007\/s12094-024-03685-0","DOI":"10.1007\/s12094-024-03685-0"},{"key":"2059_CR29","doi-asserted-by":"crossref","unstructured":"Haghighat Jahromi A, Chang G, Kurzrock R, Hoh CK (2020) Standardized uptake value (SUVmax ) in18 F-FDG PET\/CT is correlated with the total number of main oncogenic anomalies in cancer patients. Cancer Biol Ther 21:1067\u20131071","DOI":"10.1080\/15384047.2020.1834793"},{"key":"2059_CR30","doi-asserted-by":"publisher","unstructured":"Chen Z, Cheng Z, Duan Y, Zhang Q, Zhang N, Gu F, Wang Y, Zhou Y, Wang H, Liang D, Zheng H, Hu Z (2023) Accurate total\u2010body Ki parametric imaging with shortened dynamic 18F\u2010FDG PET scan durations via effective data processing. Abstr Med Phys 50(4):2121\u20132134. https:\/\/doi.org\/10.1002\/mp.15893","DOI":"10.1002\/mp.15893"},{"key":"2059_CR31","doi-asserted-by":"publisher","unstructured":"Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ\u00a0(2008) Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18 F-FDG PET. J Nucl Med 49(6):892\u2013898. https:\/\/doi.org\/10.2967\/jnumed.107.049585","DOI":"10.2967\/jnumed.107.049585"},{"key":"2059_CR32","unstructured":"Strauss LG, Dimitrakopoulou-Strauss A, Haberkorn U. Shortened PET data acquisition protocol for the quanti\ufb01cation of 18F-FDG kinetics"},{"key":"2059_CR33","doi-asserted-by":"publisher","unstructured":"Yang M, Lin Z, Xu Z, Li D, Lv W, Yang S,\u00a0Liu Y, Cao Y, Cao Q, Jin H (2020) Influx rate constant of 18F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients. Eur J Nucl Med Mol Imaging 47(5):1198\u20131208. https:\/\/doi.org\/10.1007\/s00259-020-04682-5","DOI":"10.1007\/s00259-020-04682-5"},{"key":"2059_CR34","doi-asserted-by":"publisher","unstructured":"Meijer TW, de Geus-Oei LF, Visser EP, Oyen WJ, Looijen-Salamon MG, Visvikis D, Verhagen Ad FTM, Bussink J, Vriens D (2017) Tumor delineation and quantitative assessment of glucose metabolic rate within histologic subtypes of non\u2013small cell lung cancer by using dynamic 18 f fluorodeoxyglucose PET. Radiol 283(2):547\u2013559. https:\/\/doi.org\/10.1148\/radiol.2016160329","DOI":"10.1148\/radiol.2016160329"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02059-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:37:55Z","timestamp":1768408675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02059-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02059-4","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Zhongshan Hospital (Xiamen), Fudan University (Approval No. B2022-062R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}